Search for Clinical Trial Results

Sponsored By

Schnitzler Syndrome - 7 Studies Found

Status Study
Completed Study Name: Ilaris (Canakinumab) in the Schnitzler Syndrome
Condition: Schnitzler Syndrome
Date: 2010-11-19
Interventions: Drug: Ilaris
  • Canakinumab 1
Active, not recruiting Study Name: Ilaris® Effects in Schnitzler Syndrome (ILESCH)
Condition: Schnitzler Syndrome
Date: 2011-07-07
Interventions:
  • Drug: Canakinumab 150mg subcut
Active, not recruiting Study Name: Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors
Condition: Schnitzler Syndrome
Date: 2009-07-03
Completed Study Name: Efficacy and Safety of Canakinumab in Schnitzler Syndrome
Condition: Schnitzler Syndrome
Date: 2011-01-12
Interventions: Drug: Canakinumab Monthly subcutaneous injection with 150mg Canakinumab for 6 months
Not yet recruiting Study Name: Tocilizumab in Patients With Schnitzler's Syndrome
Condition: Schnitzler's Syndrome
Date: 2017-01-05
Interventions: Drug: Tocilizumab Tocilizumab 162mg 1x weekly s.c. O
Completed Study Name: The Efficacy and Safety of ITF2357 in AIS
Condition:
  • Autoinflammatory Syndromes
  • HIDS
  • TRAPS